{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:30:05Z","timestamp":1790980205546,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1038\/ncponc0984","type":"journal-article","created":{"date-parts":[[2007,12,21]],"date-time":"2007-12-21T05:50:00Z","timestamp":1198216200000},"page":"24-31","source":"Crossref","is-referenced-by-count":191,"title":["Human papillomavirus in cervical and head-and-neck cancer"],"prefix":"10.1038","volume":"5","author":[{"given":"Amanda","family":"Psyrri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"DiMaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncponc0984_CR1","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1995) Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 64: 1\u2013378"},{"key":"BFncponc0984_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342\u2013350","journal-title":"Nat Rev Cancer"},{"key":"BFncponc0984_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00001703-199702000-00014","volume":"9","author":"CP Crum","year":"1997","unstructured":"Crum CP et al. (1997) Pathobiology of vulvar squamous neoplasia. Curr Opin Obstet Gynecol 9: 63\u201369","journal-title":"Curr Opin Obstet Gynecol"},{"key":"BFncponc0984_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S1470-2045(07)70137-7","volume":"8","author":"O Kayes","year":"2007","unstructured":"Kayes O et al. (2007) Molecular and genetic pathways in penile cancer. Lancet Oncol 8: 420\u2013429","journal-title":"Lancet Oncol"},{"key":"BFncponc0984_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","volume":"92","author":"ML Gillison","year":"2000","unstructured":"Gillison ML et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709\u2013720","journal-title":"J Natl Cancer Inst"},{"key":"BFncponc0984_CR6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ijc.11334","volume":"106","author":"SJ Goldie","year":"2003","unstructured":"Goldie SJ et al. (2003) A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16\/18 vaccine. Int J Cancer 106: 896\u2013904","journal-title":"Int J Cancer"},{"key":"BFncponc0984_CR7","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","volume":"78","author":"K Munger","year":"2004","unstructured":"Munger K et al. (2004) Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78: 11451\u201311460","journal-title":"J Virol"},{"key":"BFncponc0984_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1006\/scbi.1999.0141","volume":"9","author":"F Stubenrauch","year":"1999","unstructured":"Stubenrauch F and Laimins LA (1999) Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol 9: 379\u2013386","journal-title":"Semin Cancer Biol"},{"key":"BFncponc0984_CR9","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1128\/JVI.65.5.2254-2260.1991","volume":"65","author":"MA Bedell","year":"1991","unstructured":"Bedell MA et al. (1991) Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J Virol 65: 2254\u20132260","journal-title":"J Virol"},{"key":"BFncponc0984_CR10","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1101\/gad.9.19.2335","volume":"9","author":"S Cheng","year":"1995","unstructured":"Cheng S et al. (1995) Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev 9: 2335\u20132349","journal-title":"Genes Dev"},{"key":"BFncponc0984_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1126\/science.2157286","volume":"248","author":"BA Werness","year":"1990","unstructured":"Werness BA et al. (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76\u201379","journal-title":"Science"},{"key":"BFncponc0984_CR12","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","volume":"63","author":"M Scheffner","year":"1990","unstructured":"Scheffner M et al. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129\u20131136","journal-title":"Cell"},{"key":"BFncponc0984_CR13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1126\/science.2537532","volume":"243","author":"N Dyson","year":"1989","unstructured":"Dyson N et al. (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934\u2013937","journal-title":"Science"},{"key":"BFncponc0984_CR14","first-page":"4620","volume":"56","author":"SN Boyer","year":"1996","unstructured":"Boyer SN et al. (1996) E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin\u2013proteasome pathway. Cancer Res 56: 4620\u20134624","journal-title":"Cancer Res"},{"key":"BFncponc0984_CR15","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1128\/JVI.74.14.6622-6631.2000","volume":"74","author":"ER Flores","year":"2000","unstructured":"Flores ER et al. (2000) The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J Virol 74: 6622\u20136631","journal-title":"J Virol"},{"key":"BFncponc0984_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.virol.2005.04.036","volume":"338","author":"ME McLaughlin-Drubin","year":"2005","unstructured":"McLaughlin-Drubin ME et al. (2005) The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle. Virology 338: 61\u201368","journal-title":"Virology"},{"key":"BFncponc0984_CR17","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1128\/JVI.68.9.6097-6102.1994","volume":"68","author":"X Wu","year":"1994","unstructured":"Wu X et al. (1994) Papilloma formation by cottontail rabbit papillomavirus requires E1 and E2 regulatory genes in addition to E6 and E7 transforming genes. J Virol 68: 6097\u20136102","journal-title":"J Virol"},{"key":"BFncponc0984_CR18","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1073\/pnas.90.11.5086","volume":"90","author":"L Yang","year":"1993","unstructured":"Yang L et al. (1993) The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase. Proc Natl Acad Sci USA 90: 5086\u20135090","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncponc0984_CR19","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.1093\/nar\/21.25.5817","volume":"21","author":"FJ Hughes","year":"1993","unstructured":"Hughes FJ and Romanos MA (1993) E1 protein of human papillomavirus is a DNA helicase\/ATPase. Nucl Acids Res 21: 5817\u20135823","journal-title":"Nucl Acids Res"},{"key":"BFncponc0984_CR20","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1126\/science.2176744","volume":"250","author":"IJ Mohr","year":"1990","unstructured":"Mohr IJ et al. (1990) Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 250: 1694\u20131699","journal-title":"Science"},{"key":"BFncponc0984_CR21","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1002\/j.1460-2075.1987.tb02662.x","volume":"6","author":"F Thierry","year":"1987","unstructured":"Thierry F and Yaniv M (1987) The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J 6: 3391\u20133397","journal-title":"EMBO J"},{"key":"BFncponc0984_CR22","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1128\/JVI.72.3.2079-2088.1998","volume":"72","author":"MH Skiadopoulos","year":"1998","unstructured":"Skiadopoulos MH and McBride AA (1998) Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin. J Virol 72: 2079\u20132088","journal-title":"J Virol"},{"key":"BFncponc0984_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0092-8674(04)00402-7","volume":"117","author":"J You","year":"2004","unstructured":"You J et al. (2004) Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117: 349\u2013360","journal-title":"Cell"},{"key":"BFncponc0984_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/jhmas\/XXIV.1.65","volume":"24","author":"J Scotto","year":"1969","unstructured":"Scotto J and Bailar JC III (1969) Rigoni-Stern and medical statistics: a nineteenth-century approach to cancer research. J Hist Med Allied Sci 24: 65\u201375","journal-title":"J Hist Med Allied Sci"},{"key":"BFncponc0984_CR25","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/j.1460-2075.1984.tb01944.x","volume":"3","author":"M Boshart","year":"1984","unstructured":"Boshart M et al. (1984) A new type of papillomavirus DNA is present in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 3: 1151\u20131157","journal-title":"EMBO J"},{"key":"BFncponc0984_CR26","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1073\/pnas.80.12.3812","volume":"80","author":"M Durst","year":"1983","unstructured":"Durst M et al. (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80: 3812\u20133815","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncponc0984_CR27","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1073\/pnas.80.2.560","volume":"80","author":"L Gissmann","year":"1983","unstructured":"Gissmann L et al. (1983) Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 80: 560\u2013563","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncponc0984_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12\u201319","journal-title":"J Pathol"},{"key":"BFncponc0984_CR29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/JVI.65.2.606-612.1991","volume":"65","author":"AP Cullen","year":"1991","unstructured":"Cullen AP et al. (1991) Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 65: 606\u2013612","journal-title":"J Virol"},{"key":"BFncponc0984_CR30","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1001\/jama.286.24.3106","volume":"286","author":"NF Schlecht","year":"2001","unstructured":"Schlecht NF et al. (2001) Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286: 3106\u20133114","journal-title":"JAMA"},{"key":"BFncponc0984_CR31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1128\/JVI.65.1.473-478.1991","volume":"65","author":"CL Halbert","year":"1991","unstructured":"Halbert CL et al. (1991) The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol 65: 473\u2013478","journal-title":"J Virol"},{"key":"BFncponc0984_CR32","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1128\/JVI.67.7.3720-3729.1993","volume":"67","author":"ES Hwang","year":"1993","unstructured":"Hwang ES et al. (1993) Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene. J Virol 67: 3720\u20133729","journal-title":"J Virol"},{"key":"BFncponc0984_CR33","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/emboj\/16.3.504","volume":"16","author":"C Desaintes","year":"1997","unstructured":"Desaintes C et al. (1997) Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J 16: 504\u2013514","journal-title":"EMBO J"},{"key":"BFncponc0984_CR34","first-page":"3780","volume":"48","author":"M von Knebel Doeberitz","year":"1988","unstructured":"von Knebel Doeberitz M et al. (1988) Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res 48: 3780\u20133786","journal-title":"Cancer Res"},{"key":"BFncponc0984_CR35","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1128\/JVI.68.7.4358-4368.1994","volume":"68","author":"JM Arbeit","year":"1994","unstructured":"Arbeit JM et al. (1994) Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol 68: 4358\u20134368","journal-title":"J Virol"},{"key":"BFncponc0984_CR36","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1073\/pnas.0409883102","volume":"102","author":"T Brake","year":"2005","unstructured":"Brake T and Lambert PF (2005) Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci USA 102: 2490\u20132495","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncponc0984_CR37","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","volume":"364","author":"DM Harper","year":"2004","unstructured":"Harper DM et al. (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364: 1757\u20131765","journal-title":"Lancet"},{"key":"BFncponc0984_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","volume":"6","author":"LL Villa","year":"2005","unstructured":"Villa LL et al. (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6: 271\u2013278","journal-title":"Lancet Oncol"},{"issue":"Suppl 3","key":"BFncponc0984_CR39","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1016\/j.vaccine.2006.06.014","volume":"24","author":"LA Koutsky","year":"2006","unstructured":"Koutsky LA and Harper DM (2006) Chapter 13: current findings from prophylactic HPV vaccine trials. Vaccine 24 (Suppl 3): S114\u2013S121","journal-title":"Vaccine"},{"key":"BFncponc0984_CR40","first-page":"251","volume":"1","author":"M Durst","year":"1987","unstructured":"Durst M et al. (1987) Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1: 251\u2013256","journal-title":"Oncogene"},{"key":"BFncponc0984_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ijc.11691","volume":"109","author":"S Duensing","year":"2004","unstructured":"Duensing S and Munger K (2004) Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 109: 157\u2013162","journal-title":"Int J Cancer"},{"key":"BFncponc0984_CR42","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1038\/sj.onc.1205762","volume":"21","author":"KS Srivenugopal","year":"2002","unstructured":"Srivenugopal KS and Ali-Osman F (2002) The DNA repair protein, O(6)-methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirus oncoprotein. Oncogene 21: 5940\u20135945","journal-title":"Oncogene"},{"key":"BFncponc0984_CR43","doi-asserted-by":"publisher","first-page":"12513","DOI":"10.1073\/pnas.97.23.12513","volume":"97","author":"EC Goodwin","year":"2000","unstructured":"Goodwin EC and DiMaio D (2000) Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci USA 97: 12513\u201312518","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncponc0984_CR44","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1056\/NEJMoa065497","volume":"356","author":"G D'Souza","year":"2007","unstructured":"D'Souza G et al. (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356: 1944\u20131956","journal-title":"N Engl J Med"},{"key":"BFncponc0984_CR45","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1200\/JCO.2004.00.3335","volume":"24","author":"PM Weinberger","year":"2006","unstructured":"Weinberger PM et al. (2006) Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favourable prognosis. J Clin Oncol 24: 736\u2013747","journal-title":"J Clin Oncol"},{"key":"BFncponc0984_CR46","first-page":"5","volume":"58","author":"T Andl","year":"1998","unstructured":"Andl T et al. (1998) Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58: 5\u201313","journal-title":"Cancer Res"},{"key":"BFncponc0984_CR47","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/S0140-6736(99)92824-6","volume":"354","author":"M Frisch","year":"1999","unstructured":"Frisch M and Biggar RJ (1999) Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet 354: 1442\u20131443","journal-title":"Lancet"},{"key":"BFncponc0984_CR48","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/cncr.20998","volume":"103","author":"CH Shiboski","year":"2005","unstructured":"Shiboski CH et al. (2005) Tongue and tonsil carcinoma: increasing trends in the US population ages 20\u201344 years. Cancer 103: 1843\u20131849","journal-title":"Cancer"},{"key":"BFncponc0984_CR49","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1023\/A:1008918223334","volume":"11","author":"M Frisch","year":"2000","unstructured":"Frisch M et al. (2000) Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 11: 489\u2013495","journal-title":"Cancer Causes Control"},{"key":"BFncponc0984_CR50","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S1368-8375(01)00109-9","volume":"38","author":"MT Canto","year":"2002","unstructured":"Canto MT and Devesa SS (2002) Oral cavity and pharynx cancer incidence rates in the United States, 1975\u20131998. Oral Oncol 38: 610\u2013617","journal-title":"Oral Oncol"},{"key":"BFncponc0984_CR51","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/NEJM199710163371601","volume":"337","author":"DT Fleming","year":"1997","unstructured":"Fleming DT et al. (1997) Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337: 1105\u20131111","journal-title":"N Engl J Med"},{"key":"BFncponc0984_CR52","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1093\/jnci\/90.21.1626","volume":"90","author":"SM Schwartz","year":"1998","unstructured":"Schwartz SM et al. (1998) Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90: 1626\u20131636","journal-title":"J Natl Cancer Inst"},{"key":"BFncponc0984_CR53","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00008469-200012000-00010","volume":"9","author":"K Hemminki","year":"2000","unstructured":"Hemminki K et al. (2000) Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev 9: 433\u2013437","journal-title":"Eur J Cancer Prev"},{"key":"BFncponc0984_CR54","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1056\/NEJM200104123441503","volume":"344","author":"J Mork","year":"2001","unstructured":"Mork J et al. (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344: 1125\u20131131","journal-title":"N Engl J Med"},{"key":"BFncponc0984_CR55","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1080\/00016480510043945","volume":"125","author":"BG Hansson","year":"2005","unstructured":"Hansson BG et al. (2005) Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 125: 1337\u20131344","journal-title":"Acta Otolaryngol"},{"key":"BFncponc0984_CR56","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1093\/jnci\/djg107","volume":"95","author":"R Herrero","year":"2003","unstructured":"Herrero R et al. (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95: 1772\u20131783","journal-title":"J Natl Cancer Inst"},{"key":"BFncponc0984_CR57","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ijc.11633","volume":"108","author":"EM Smith","year":"2004","unstructured":"Smith EM et al. (2004) Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 108: 766\u2013772","journal-title":"Int J Cancer"},{"key":"BFncponc0984_CR58","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/jnci\/92.9.680","volume":"92","author":"C McNeil","year":"2000","unstructured":"McNeil C (2000) HPV in oropharyngeal cancers: new data inspire hope for vaccines. J Natl Cancer Inst 92: 680\u2013681","journal-title":"J Natl Cancer Inst"},{"key":"BFncponc0984_CR59","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S0300-9785(83)80033-7","volume":"12","author":"K Syrjanen","year":"1983","unstructured":"Syrjanen K et al. (1983) Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 12: 418\u2013424","journal-title":"Int J Oral Surg"},{"key":"BFncponc0984_CR60","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ijc.2910360510","volume":"36","author":"EM de Villiers","year":"1985","unstructured":"de Villiers EM et al. (1985) Papillomavirus DNA in human tongue carcinomas. Int J Cancer 36: 575\u2013578","journal-title":"Int J Cancer"},{"key":"BFncponc0984_CR61","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF00049489","volume":"15","author":"BM Steinberg","year":"1996","unstructured":"Steinberg BM and DiLorenzo TP (1996) A possible role for human papillomaviruses in head and neck cancer. Cancer Metastasis Rev 15: 91\u2013112","journal-title":"Cancer Metastasis Rev"},{"key":"BFncponc0984_CR62","first-page":"1614","volume":"57","author":"Z Chen","year":"1997","unstructured":"Chen Z et al. (1997) Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences. Cancer Res 57: 1614\u20131619","journal-title":"Cancer Res"},{"key":"BFncponc0984_CR63","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/bjc.1987.185","volume":"56","author":"NJ Maitland","year":"1987","unstructured":"Maitland NJ et al. (1987) Detection of human papillomavirus DNA in biopsies of human oral tissue. Br J Cancer 56: 245\u2013250","journal-title":"Br J Cancer"},{"key":"BFncponc0984_CR64","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1099\/0022-1317-72-1-173","volume":"72","author":"WA Yeudall","year":"1991","unstructured":"Yeudall WA and Campo MS (1991) Human papillomavirus DNA in biopsies of oral tissues. J Gen Virol 72: 173\u2013176","journal-title":"J Gen Virol"},{"key":"BFncponc0984_CR65","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ijc.10669","volume":"102","author":"H Mellin","year":"2002","unstructured":"Mellin H et al. (2002) Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102: 152\u2013158","journal-title":"Int J Cancer"},{"key":"BFncponc0984_CR66","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1073\/pnas.0306848101","volume":"101","author":"BA Van Tine","year":"2004","unstructured":"Van Tine BA et al. (2004) Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc Natl Acad Sci USA 101: 4030\u20134035","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncponc0984_CR67","first-page":"6078","volume":"54","author":"Y Li","year":"1994","unstructured":"Li Y et al. (1994) Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54: 6078\u20136082","journal-title":"Cancer Res"},{"key":"BFncponc0984_CR68","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1128\/MCB.16.3.859","volume":"16","author":"E Hara","year":"1996","unstructured":"Hara E et al. (1996) Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16: 859\u2013867","journal-title":"Mol Cell Biol"},{"key":"BFncponc0984_CR69","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/01.MP.0000077518.78046.0C","volume":"16","author":"SN Agoff","year":"2003","unstructured":"Agoff SN et al. (2003) p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 16: 665\u2013673","journal-title":"Mod Pathol"},{"key":"BFncponc0984_CR70","first-page":"6469","volume":"9","author":"S Begum","year":"2003","unstructured":"Begum S et al. (2003) Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 9: 6469\u20136475","journal-title":"Clin Cancer Res"},{"key":"BFncponc0984_CR71","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00001622-199505000-00007","volume":"7","author":"D Sidransky","year":"1995","unstructured":"Sidransky D (1995) Molecular genetics of head and neck cancer. Curr Opin Oncol 7: 229\u2013233","journal-title":"Curr Opin Oncol"},{"key":"BFncponc0984_CR72","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00001622-200105000-00009","volume":"13","author":"ML Gillison","year":"2001","unstructured":"Gillison ML and Shah KV (2001) Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 13: 183\u2013188","journal-title":"Curr Opin Oncol"},{"key":"BFncponc0984_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1067\/mhn.2001.116979","volume":"125","author":"SR Schwartz","year":"2001","unstructured":"Schwartz SR et al. (2001) Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 125: 1\u20139","journal-title":"Otolaryngol Head Neck Surg"},{"key":"BFncponc0984_CR74","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<595::AID-CNCR24>3.0.CO;2-Y","volume":"79","author":"IB Paz","year":"1997","unstructured":"Paz IB et al. (1997) Human papillomavirus (HPV) in head and neck cancer: an association of HPV16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 79: 595\u2013604","journal-title":"Cancer"},{"key":"BFncponc0984_CR75","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1200\/JCO.2005.04.6136","volume":"24","author":"L Licitra","year":"2006","unstructured":"Licitra L et al. (2006) High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24: 5630\u20135636","journal-title":"J Clin Oncol"},{"key":"BFncponc0984_CR76","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/ijc.10960","volume":"104","author":"JM Ritchie","year":"2003","unstructured":"Ritchie JM et al. (2003) Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104: 336\u2013344","journal-title":"Int J Cancer"},{"key":"BFncponc0984_CR77","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9","volume":"92","author":"K Lindel","year":"2001","unstructured":"Lindel K et al. (2001) Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 92: 805\u2013813","journal-title":"Cancer"},{"key":"BFncponc0984_CR78","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/ijc.11261","volume":"106","author":"W Li","year":"2003","unstructured":"Li W et al. (2003) Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 106: 553\u2013558","journal-title":"Int J Cancer"},{"key":"BFncponc0984_CR79","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","volume":"6","author":"DP Slaughter","year":"1953","unstructured":"Slaughter DP et al. (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6: 963\u2013968","journal-title":"Cancer"},{"key":"BFncponc0984_CR80","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/(SICI)1097-0215(19961115)68:4<506::AID-IJC17>3.0.CO;2-2","volume":"68","author":"K Butz","year":"1996","unstructured":"Butz K et al. (1996) Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6\/E7-oncogene expression and induction of apoptosis. Int J Cancer 68: 506\u2013513","journal-title":"Int J Cancer"},{"key":"BFncponc0984_CR81","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/ncponc0770","volume":"4","author":"CM Wheeler","year":"2007","unstructured":"Wheeler CM et al. (2007) Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing. Nat Clin Pract Oncol 4: 224\u2013235","journal-title":"Nat Clin Pract Oncol"},{"key":"BFncponc0984_CR82","doi-asserted-by":"crossref","unstructured":"FUTURE II Study Group (2007) Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356: 1915\u20131927","DOI":"10.1056\/NEJMoa061741"},{"key":"BFncponc0984_CR83","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/376505","volume":"188","author":"LA Pinto","year":"2003","unstructured":"Pinto LA et al. (2003) Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. J Infect Dis 188: 327\u2013338","journal-title":"J Infect Dis"},{"key":"BFncponc0984_CR84","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/eji.1830230929","volume":"23","author":"MC Feltkamp","year":"1993","unstructured":"Feltkamp MC et al. (1993) Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol 23: 2242\u20132249","journal-title":"Eur J Immunol"},{"key":"BFncponc0984_CR85","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0140-6736(96)90674-1","volume":"347","author":"LK Borysiewicz","year":"1996","unstructured":"Borysiewicz LK et al. (1996) A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 347: 1523\u20131527","journal-title":"Lancet"}],"container-title":["Nature Clinical Practice Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncponc0984.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc0984","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncponc0984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc0984.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:50:03Z","timestamp":1684428603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncponc0984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["BFncponc0984"],"URL":"https:\/\/doi.org\/10.1038\/ncponc0984","relation":{},"ISSN":["1743-4254","1743-4262"],"issn-type":[{"value":"1743-4254","type":"print"},{"value":"1743-4262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}